4.8 Article

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

Journal

SCIENCE
Volume 368, Issue 6494, Pages 973-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aay9189

Keywords

-

Funding

  1. Israel Science Foundation [2044/17]
  2. Binational Science Foundation [2013332]
  3. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [818086]
  4. Fabrikant-Morse Families Research Fund for Humanity
  5. Chantal d'Adesky Scheinberg Research Fund
  6. Moross Integrated Cancer Center
  7. Rising Tide Foundation
  8. Jacki and Bruce Barron Cancer Research Scholars' Program
  9. Israel Cancer Research Fund
  10. City of Hope (COH) - Harvey L. Miller Family Foundation
  11. Ministry of Science, Technology and Space, Israel [3-11174]
  12. National Cancer Institute of the National Institutes of Health [P30CA033572]
  13. Cancer Prevention and Research Institute of Texas Research Training Program [RP170067]
  14. European Research Council (ERC) [818086] Funding Source: European Research Council (ERC)
  15. Directorate for STEM Education
  16. Division Of Undergraduate Education [2013332] Funding Source: National Science Foundation

Ask authors/readers for more resources

Bacteria were first detected in human tumors more than 100 years ago, but the characterization of the tumor microbiome has remained challenging because of its low biomass. We undertook a comprehensive analysis of the tumor microbiome, studying 1526 tumors and their adjacent normal tissues across seven cancer types, including breast, lung, ovary, pancreas, melanoma, bone, and brain tumors. We found that each tumor type has a distinct microbiome composition and that breast cancer has a particularly rich and diverse microbiome. The intratumor bacteria are mostly intracellular and are present in both cancer and immune cells. We also noted correlations between intratumor bacteria or their predicted functions with tumor types and subtypes, patients' smoking status, and the response to immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available